Grape polyphenols to prevent heart damage from chemo
Part of Cancer, Skin clinical trials.
This trial tests whether grape polyphenols can help protect the heart in women being treated for breast cancer with certain chemotherapy drugs that can harm the heart. If you are at high risk for heart problems from chemo, this study may offer a way to reduce that risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 30 and 75 years old.
- You have been diagnosed with breast cancer and are planning to receive chemotherapy with anthracycline or trastuzumab drugs.
- Your doctor has determined you have a high or very high risk (at least 20%) of heart damage from the chemotherapy.
- You are able to take study products by mouth and agree to follow study procedures and visits.
- You do not have severe heart disease, uncontrolled high blood pressure, or serious liver or kidney problems.
- You are not allergic to grapes or grape products and are not taking part in another trial that could interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two different medications (SGLT-2 inhibitor vs. DPP-4 inhibitor) can help prevent heart damage from certain chemotherapy drugs (anthracyclines) in women with breast cancer. It aims to protect your heart while you undergo cancer treatment.
This trial tests if a special diet can help prevent heart problems caused by chemotherapy in women with triple negative breast cancer. If you're starting a specific type of chemo, you may be able to join.
This trial tests if taking rosuvastatin (a cholesterol-lowering pill) can help prevent heart damage from anthracycline chemotherapy in women with breast cancer. If you are about to start this type of chemo and have not used statins before, you may qualify.
This trial checks how well the heart handles anthracycline chemotherapy in breast cancer patients. It helps doctors find early signs of heart side effects so they can keep you safe during treatment.
This trial tests if a medicine called pentoxifylline can help prevent heart damage caused by doxorubicin, a common chemotherapy drug for breast cancer. If you are starting doxorubicin for the first time, this study may offer added heart protection.
This study tests whether careful blood pressure management can help protect the heart during certain types of chemotherapy (anthracyclines) for breast cancer. Participants will use a smart blood pressure device and may also do an exercise test.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.